Dr. Reddy's Laboratories Ltd - Company Profile
Powered by 
All the data and insights you need on Dr. Reddy's Laboratories Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Dr. Reddy's Laboratories Ltd Strategy Report
- Understand Dr. Reddy's Laboratories Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Dr. Reddy's Laboratories Ltd (Dr. Reddy's) is a pharmaceutical company. It conducts the manufacture and distribution of active pharmaceutical ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations. The company provides prescription, generics, branded generics and OTC products.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
In the area of generics and formulations, the R&D activities are directed at the development of process validation, product formulations, bioequivalence testing and other data needed to prepare drugs that are equivalent to numerous branded products for sale in the emerging markets. In the active pharmaceutical ingredients and intermediates, the R&D activities concentrate on the development of chemical processes for the synthesis of active pharmaceutical ingredients for use in the generics and formulations segments and for sales in the emerging and developed markets to third parties. In the area of Drug discovery, the company is pursuing discovery and development of biosimilars, new chemical entities (NCEs), and differentiated formulations. The research programs focus on disease areas such as metabolic disorders, cardiovascular disorders, bacterial infections, inflammation, and cancer. In case of the Custom pharmaceutical services, Dr. Reddy's strives to strengthen its ability in process chemistry and finished dosage development with the aim of targeting innovator and emerging pharmaceutical companies. Its R&D program is designed to provide services supporting the entire pharmaceutical value chain. In FY2023, the company spent INR19,381 million on its R&D activities, which as a percentage of revenue stood at 7.9%. As of March 31, 2032, the company had more than 1,550 trademarks filed with the Registrar of Trademarks in India. The company has 1,071 patents filed and also published over 1,000 papers for peer review. It has a R&D team that consisting of more than 150 doctorates.
Business Segments
Overview
-Produces and distributes over-the-counter (OTC), unbranded, branded prescribed drugs, and biosimilars. -Consists of generic drugs, which are chemical and therapeutic equivalents of reference brand drugs. -Distributes its generic products in the markets of North America and Europe. -Also serves rural markets in India through an exclusive portfolio of products aimed at the needs of the rural population.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Includes the operations of the company’s subsidiary, Aurigene Discovery Technologies Ltd, a discovery stage biotechnology company that develops novel therapies in the areas of inflammation and oncology. Works in collaboration with various biotechnology and pharmaceutical companies to advance the development of early-stage drug candidates from lead generation stage to pre-clinical development.
Overview
-Conducts research and focuses on the manufacture of differentiated formulations and new chemical entities (NCEs) in the therapeutic areas of dermatology and neurology. -Markets its product through Promius Pharma LLC.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Comprises active pharmaceutical ingredients (APIs) and intermediates and custom pharmaceutical services. APIs are the principal ingredients for finished dosages and are also known as bulk actives or bulk drugs. Also manufactures and sells APIs required for its custom pharmaceutical services businesses. Operates an R&D center, which continually strives to develop new products and reduce the cost of production of its products. The R&D center develops 15-20 new products per year. The company holds 51.3% interest in Reddy Kunshan, a joint venture (JV) in China, which manufactures and markets active pharmaceutical ingredients and intermediates and formulations in China.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer